Search results for "PASS"

showing 10 items of 1629 documents

Single-centre, triple-blinded, randomised, 1-year, parallel-group, superiority study to compare the effects of Roux-en-Y gastric bypass and sleeve ga…

2019

IntroductionBariatric surgery is increasingly recognised as an effective treatment option for subjects with type 2 diabetes and obesity; however, there is no conclusive evidence on the superiority of Roux-en-Y gastric bypass or sleeve gastrectomy. The Oseberg study was designed to compare the effects of gastric bypass and sleeve gastrectomy on remission of type 2 diabetes and β-cell function.Methods and analysisSingle-centre, randomised, triple-blinded, two-armed superiority trial carried out at the Morbid Obesity Centre at Vestfold Hospital Trust in Norway. Eligible patients with type 2 diabetes and obesity were randomly allocated in a 1:1 ratio to either gastric bypass or sleeve gastrecto…

Malemedicine.medical_specialtySleeve gastrectomyβ-cell functionmedicine.medical_treatment1843Gastric BypassBariatric Surgery030209 endocrinology & metabolismType 2 diabeteslaw.invention03 medical and health sciences0302 clinical medicineSuperiority TrialRandomized controlled trialClinical ProtocolslawGastrectomyDiabetes mellitusInternal medicineInsulin-Secreting CellsmedicineProtocolHumans030212 general & internal medicine1506VDP::Medisinske Fag: 700::Klinisk medisinske fag: 750::Kardiologi: 771Glycated Hemoglobinbusiness.industryNorwayGeneral Medicinemedicine.diseaseRoux-en-Y anastomosismorbid obesityObesity MorbidDiabetes and EndocrinologyTreatment OutcomeDiabetes Mellitus Type 2GastrectomyFemaleLaparoscopytype 2 diabetesbusinessEpidemiologic MethodsBody mass indexrandomised controlled trialsleeve gastrectomy
researchProduct

Thrombolysis with saruplase versus streptokinase in acute myocardial infarction: five-year results of the PRIMI trial.

1999

Abstract Background Short-term safety and efficacy of thrombolysis with saruplase in acute myocardial infarction have been shown in several trials. To assess long-term outcome of patients treated with saruplase or streptokinase for myocardial infarction, a 5-year follow-up of patients included in the Pro-Urokinase in Myocardial Infarction Trial was performed. Methods and Results Follow-up data are available from 8 centers on 255 (92.4%) of 276 included patients. The 5-year mortality rate was comparable with 20.8% of patients in the saruplase group and 16.9% in the streptokinase group (odds ratio 1.29, 95% confidence interval 0.69 to 2.42). In both groups, a considerable number of fatal card…

Malemedicine.medical_specialtyStreptokinasemedicine.medical_treatmentMyocardial InfarctionAnginaCohort StudiesFibrinolytic AgentsRecurrenceAngioplastyInternal medicineMedicineHumansStreptokinaseThrombolytic TherapyMyocardial infarctionAngioplasty Balloon CoronaryCoronary Artery BypassAgedbusiness.industryOdds ratioThrombolysisMiddle Agedmedicine.diseaseSurvival AnalysisUrokinase-Type Plasminogen ActivatorConfidence intervalRecombinant ProteinsCerebrovascular DisordersCardiologySaruplaseFemaleCardiology and Cardiovascular Medicinebusinessmedicine.drugFollow-Up StudiesAmerican heart journal
researchProduct

Epistaxis and systemic disease

2008

Abstract We report the case of a 77-year-old man who presented nasal obstruction sensation and epistaxis. Otorhinolaryngologic examination revealed occupation of the left nasal passage and the left maxillary sinus by an inflammatory tumour, the biopsy results of which were inconclusive. While diagnostic tests were being carried out, the patient presented a severe systemic condition consisting mainly of anemia, acute renal failure, and cavitated diffuse bilateral lung infiltrates. In the light of the results of anti-neutrophilic cytoplasmic antibodies and renal biopsy, Wegener's granulomatosis was diagnosed and treatment for the disease was instituted, with a favourable response. Finally, cl…

Malemedicine.medical_specialtySystemic diseaseMaxillary Sinus NeoplasmsAnemiaBiopsyComorbidityDiseaseRenal DialysisTrimethoprim Sulfamethoxazole Drug CombinationBiopsyHumansMedicineCyclophosphamideGlucocorticoidsAgedNasal passagesLungPapillomamedicine.diagnostic_testGlomerulosclerosis Focal Segmentalbusiness.industryGranulomatosis with PolyangiitisAnemiaGeneral MedicineAcute Kidney Injurymedicine.diseaseLeft maxillary sinusDermatologySurgeryEpistaxismedicine.anatomical_structureRenal biopsyNasal ObstructionLung Diseases InterstitialTomography X-Ray ComputedbusinessActa Otorrinolaringologica (English Edition)
researchProduct

External polytetrafluoroethylene reinforcement of varicose autologous vein grafts in peripheral bypass surgery produces durable bypass function

2017

Abstract Objective Use of autologous veins as peripheral bypass graft may become critical in the presence of significant varicose degeneration of the harvested vein. External support of such dilated veins with standard polytetrafluoroethylene (PTFE) prostheses was recommended as an option to use these veins for peripheral bypass. A single-center experience with this technique regarding long-term graft function, secondary reinterventions, and potential graft degeneration is presented. Methods Between January 1995 and January 2006, there were 54 patients with varicose veins who underwent 57 consecutive infrainguinal vein bypass operations with PTFE reinforcement in 57 limbs. Indications for s…

Malemedicine.medical_specialtyTime Factors030204 cardiovascular system & hematology030230 surgeryTransplantation AutologousVaricose VeinsPopliteal aneurysm03 medical and health sciences0302 clinical medicineGermanyVaricose veinsmedicineHumansSaphenous VeinVeinPolytetrafluoroethyleneAgedRetrospective StudiesAged 80 and overUltrasonography Doppler Duplexmedicine.diagnostic_testbusiness.industryIncidenceGraft SurvivalAngiographyGraft Occlusion VascularMiddle Agedmedicine.diseaseSurgerySurvival RateTransplantationStenosismedicine.anatomical_structureBypass surgeryAngiographyFemaleVascular GraftingSurgerymedicine.symptomCardiology and Cardiovascular MedicinebusinessClaudicationFollow-Up StudiesJournal of Vascular Surgery
researchProduct

Graft patency and late outcomes for patients with ST-segment elevation myocardial infarction who underwent coronary surgery

2011

Objective: The aim of our study was to assess the long-term clinical outcomes and the grafts patency rates of patients with ST-segment elevation myocardial infarction (STEMI) who underwent urgent or emergency coronary artery bypass grafting (CABG). Materials: Participants in two previous studies comprising 207 STEMI patients undergoing on-pump (145 patients) or off-pump (62 patients) coronary artery bypass graft (CABG) surgery in our institution were prospectively followed to assess late mortality, graft patency, and major adverse cardiac-related event (MACE) rates. Graft patency was evaluated by multi-detector computed tomography angiography 64-slice scan. Mean times of graft implantation…

Malemedicine.medical_specialtyTime FactorsCoronary Artery Bypass Off-PumpDisease-Free SurvivalBlood vessel prosthesisInternal medicinemedicineHumansVascular PatencyRadiology Nuclear Medicine and imagingProspective StudiesMyocardial infarctionProspective cohort studySurvival rateVascular PatencyAgedAdvanced and Specialized Nursingbusiness.industryMortality rateGeneral MedicineMiddle Agedmedicine.diseaseBlood Vessel Prosthesiscoronary artery bypassSurvival RateCoronary arteriesMyocardial infarctionsurgical procedures operativemedicine.anatomical_structureCardiologyFemaleCardiology and Cardiovascular MedicinebusinessSafety ResearchMaceFollow-Up StudiesPerfusion
researchProduct

Value of the deep femoral artery as alternative inflow source in infrainguinal bypass surgery.

2013

Background The purpose of this study was to analyze the long-term results of infrainguinal bypass surgery using the deep femoral artery (DFA) as the inflow source. Methods Between 1998 and 2011, 88 bypasses of the lower limb were placed in 86 patients (mean age 71 years) using the deep femoral artery as inflow. Patients' records were retrieved from a computerized database and analyzed retrospectively. Results Critical limb ischemia (rest pain/tissue loss) was the indication in the majority (87.5%) of cases. The distal anastomosis of the bypass grafts was located at the popliteal level in 32 cases and the tibial (pedal) level in 52 cases, respectively, with the autologous vein as conduit in …

Malemedicine.medical_specialtyTime FactorsInfrainguinal bypassCritical IllnessInflowFemoral arteryKaplan-Meier EstimateIschemiamedicine.arterymedicineDeep Femoral ArteryHumansVascular PatencyAgedRetrospective StudiesAged 80 and overPeripheral Vascular DiseasesGroinbusiness.industryGeneral MedicineCritical limb ischemiaPerioperativeMiddle Agedmedicine.diseaseLimb SalvageSurgeryFemoral Arterymedicine.anatomical_structureTreatment OutcomeLower ExtremitySurgeryVascular GraftingRadiologymedicine.symptomCardiology and Cardiovascular MedicinebusinessCalcificationAnnals of vascular surgery
researchProduct

Low lymphocyte count in acute phase of ST-segment elevation myocardial infarction predicts long-term recurrent myocardial infarction

2010

Objective We sought to determine the relationship between the lowest lymphocyte count (lymphocyte(min))obtained within the first 96 h of symptoms onset and the risk of postdischarge recurrent spontaneous myocardial infarction (re-MI) in patients admitted with ST-segment elevation MI (STEMI). Methods We analyzed 549 consecutive patients admitted with STEMI from a single academic hospital. Lymphocyte counts were determined at admission and routinely during the first 96 h. Lymphocyte(min) was selected as the main exposure. Patients with inflammatory or infectious diseases, in-hospital death, or reinfarction were excluded from the analysis (final sample= 426 patients). Lymphocyte(min) was divid…

Malemedicine.medical_specialtyTime FactorsLymphocyteMyocardial InfarctionRisk AssessmentPatient AdmissionRecurrenceRisk FactorsInternal medicinemedicineHumansST segmentLymphocyte CountLymphocytesRegistriesMyocardial infarctionAngioplasty Balloon CoronaryCoronary Artery BypassAgedProportional Hazards Modelsbusiness.industryProportional hazards modelHazard ratioElectrocardiography in myocardial infarctionGeneral MedicineMiddle Agedmedicine.diseasePatient DischargeConfidence intervalTreatment Outcomemedicine.anatomical_structureQuartileCardiologyFemaleCardiology and Cardiovascular MedicinebusinessCoronary Artery Disease
researchProduct

The DETOUR procedure: no more need for conventional bypass surgery?

2018

Background Long segment occlusive disease in the superficial femoral artery remains a treatment challenge despite advances in open surgical and endovascular approaches. We report initial clinical results of an entirely new procedure to perform percutaneous femoro-popliteal bypass using the DETOUR System. First-in-human patients were performed in New Zealand from December 2013 to June 2014. After modifications to the technique and devices had significantly refined the procedure, the Detour I Trial commenced. Methods Review of initial results in the first five patients treated at a single site enrolled in IRB-approved, prospective clinical study using the DETOUR System. All patients signed in…

Malemedicine.medical_specialtyTime FactorsPercutaneousComputed Tomography AngiographyDeep veinmedicine.medical_treatmentFemoral veinConstriction PathologicFemoral artery030204 cardiovascular system & hematology030218 nuclear medicine & medical imagingBlood Vessel Prosthesis ImplantationPeripheral Arterial Disease03 medical and health sciences0302 clinical medicineRecurrenceBlood vessel prosthesismedicine.arterymedicineHumansProspective StudiesVascular PatencyAgedAged 80 and overbusiness.industryEndovascular ProceduresStentPhlebographyGeneral MedicineMiddle AgedLatviaPopliteal arteryBlood Vessel ProsthesisSurgeryFemoral ArteryTreatment Outcomemedicine.anatomical_structureBypass surgeryFemaleStentsSurgeryCardiology and Cardiovascular MedicinebusinessThe Journal of Cardiovascular Surgery
researchProduct

Corticospinal Modulations during Motor Imagery of Concentric, Eccentric, and Isometric Actions

2019

PURPOSE It is not known yet whether the neurophysiological specificity of eccentric, concentric, and isometric contractions can also be observed when these are mentally simulated. Therefore, our aim was to assess corticospinal excitability during motor imagery (MI) of different contraction types and to test whether a passive movement during MI could have additional effects. METHODS Twelve young participants imagined contractions of the wrist flexors, firstly with the arm motionless (static mode) and second, with a congruent passive movement (wrist extension during eccentric MI and wrist flexion during concentric MI). Motor-evoked potentials (MEP) and H-reflexes were elicited in flexor carpi…

Malemedicine.medical_specialty[SDV.IB.IMA]Life Sciences [q-bio]/Bioengineering/ImagingPyramidal TractsPhysical Therapy Sports Therapy and RehabilitationIsometric exerciseWristConcentricH-Reflex03 medical and health sciencesPassive movementsYoung Adult0302 clinical medicineMotor imageryPhysical medicine and rehabilitationFeedback SensoryStatic modeIsometric Contractionmedicine[INFO.INFO-IM]Computer Science [cs]/Medical ImagingEccentricHumansOrthopedics and Sports Medicinebusiness.industryElectromyography030229 sport sciencesNeurophysiologyNeurofeedbackEvoked Potentials MotorTranscranial Magnetic StimulationElectric Stimulationmedicine.anatomical_structureImaginationbusinessMuscle Contraction
researchProduct

The FAST-MI 2005-2010-2015 registries in the light of the COMPASS trial: The COMPASS criteria applied to a post-MI population.

2019

International audience; Background: The COMPASS trial assessed the impact of adding low dose rivaroxaban to aspirin in selected patients (pts). After an acute myocardial infarction (MI), when dual antiplatelet treatment is no longer needed, patients might be eligible for aspirin/rivaroxaban co-therapy. The characteristics and risks of such a population are unclear.Methods: Data were extracted from the FAST-MI 2005, 2010 and 2015 nationwide French registries. Characteristics and long-term mortality were compared according to COMPASS eligibility and between registry and trial populations.Results: Among 9954 patients alive and free of events at one year, 4402 (44%) were classified as COMPASS-L…

Malemedicine.medical_specialtyanimal structuresPopulationMyocardial Infarction030204 cardiovascular system & hematologyCoronary artery diseaselaw.inventionCoronary artery diseaseCohort Studies03 medical and health sciences0302 clinical medicine[SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular systemRandomized controlled trialRivaroxabanlawCompassInternal medicinemedicineHumans030212 general & internal medicineMyocardial infarctionRegistrieseducationAgedAged 80 and overIschemic and hemorrhagic riskAspirinRivaroxabaneducation.field_of_studyAspirinbusiness.industryAnticoagulantsMiddle Agedmedicine.disease[SDV.MHEP.CSC] Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system3. Good healthIncreased risk[SDV.SP.PHARMA] Life Sciences [q-bio]/Pharmaceutical sciences/PharmacologyPopulation SurveillanceCOMPASS study[SDV.SP.PHARMA]Life Sciences [q-bio]/Pharmaceutical sciences/PharmacologyFemaleFranceCardiology and Cardiovascular MedicinebusinessPlatelet Aggregation Inhibitorsmedicine.drugFollow-Up StudiesInternational journal of cardiology
researchProduct